As a junior doctor in her mid-thirties, working an average of 80 hours a week while raising young children, Cathy Wield found ...

The primary path to full approval from conditional approval is the pivotal efficacy study—a tightly controlled, high-quality ...

certain clinical trials or studies of adverse drug reactions. The team also developed safeguards against confounding factors ...

If you opt for this particular drive-thru to avoid a certain ingredient, beware—almost 5,000 pounds of product may be ...

A collaboration between Rice University, Baylor College of Medicine and Texas Children's Hospital's Jan and Dan Duncan ...

It’s no surprise then that Lexapro is one of the most recognizable drug names ... For example, if you’re prone to insomnia, try taking escitalopram in the morning. In rare cases, it's possible to have ...

A collaboration among Rice University, Baylor College of Medicine and Texas Children's Hospital's Jan and Dan Duncan ...

ALX hopes to gain insights by tracking EGFR expression in a new trial of ALX2004 and to identify best responders using CD47 expression in a trial of evorpacept.

The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a ...

The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...

The FDA has started reporting real-time data about adverse events through the FDA Adverse Event Reporting System, improving ...

The FDA now provides daily updates on adverse event reports for drugs and biologics via FAERS. Read more here.